======= LNPEP ======= == Gene Information == * **Official Symbol**: LNPEP * **Official Name**: leucyl and cystinyl aminopeptidase * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=4012|4012]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9UIQ6|Q9UIQ6]] * **Interactions**: [[https://thebiogrid.org/search.php?search=LNPEP&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20LNPEP|Open PubMed]] * **OMIM**: [[https://omim.org/entry/151300|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Release of an N-terminal amino acid, cleaves before cysteine, leucine as well as other amino acids. Degrades peptide hormones such as oxytocin, vasopressin and angiotensin III, and plays a role in maintaining homeostasis during pregnancy. May be involved in the inactivation of neuronal peptides in the brain. Cleaves Met-enkephalin and dynorphin. Binds angiotensin IV and may be the angiotensin IV receptor in the brain. {ECO:0000269|PubMed:11389728, ECO:0000269|PubMed:11707427, ECO:0000269|PubMed:1731608}. |Peptidase M1| |early endosome lumen| |antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent| |metalloaminopeptidase activity| |aminopeptidase activity| |peptide catabolic process| |negative regulation of cold-induced thermogenesis| |peptide binding| |SMAD protein signal transduction| |metallopeptidase activity| |antigen processing and presentation of exogenous peptide antigen via MHC class I| |antigen processing and presentation of peptide antigen via MHC class I| |cytoplasmic vesicle membrane| |regulation of cold-induced thermogenesis| |antigen processing and presentation of exogenous peptide antigen| |female pregnancy| |antigen processing and presentation of exogenous antigen| |antigen processing and presentation of peptide antigen| |transmembrane receptor protein serine/threonine kinase signaling pathway| |multi-multicellular organism process| |antigen processing and presentation| |protein polyubiquitination| |lysosomal membrane| |peptide metabolic process| |protein catabolic process| |protein ubiquitination| |perinuclear region of cytoplasm| |enzyme linked receptor protein signaling pathway| |protein modification by small protein conjugation| |cellular amide metabolic process| |zinc ion binding| |protein modification by small protein conjugation or removal| |multi-organism reproductive process| |macromolecule catabolic process| |organonitrogen compound catabolic process| |cell-cell signaling| |negative regulation of multicellular organismal process| |proteolysis| |integral component of plasma membrane| |reproductive process| |reproduction| |organic substance catabolic process| |cellular catabolic process| |extracellular region| |membrane| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp1|5-Fluorouracil 2μM R00 exp1]]|1.73| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|1.78| |[[:results:exp470|Chloroquine 32μM R08 exp470]]|1.83| |[[:results:exp29|Rapamycin 1μM R00 exp29]]|1.84| |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|2.01| |[[:results:exp155|UNC1999 2μM R03 exp155]]|2.22| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12746 * **Expression level (log2 read counts)**: 7.58 {{:chemogenomics:nalm6 dist.png?nolink |}}